Phase II trial of enzastaurin (Enz) with bevacizumab (BV) in adults with recurrent glioblstoma (GBM).

被引：1
|
作者：
Moustakas, A.
Iwamoto, F. M.
Kreisl, T. N.
Sul, J.
Kim, L. J.
Butman, J. A.
Albert, P. S.
Fine, H. A.
机构：
[1] NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA
[2] Univ Massachusetts, Sch Med, Worcester, MA USA
[3] NIH, Bethesda, MD 20892 USA
[4] NCI, NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e12511
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12511
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Bevacizumab (BV) plus irinotecan (I) in recurrent glioblastoma multiforme (GBM): A single center experience.
    Iruarrizaga, Eluska
    Azkona, Eider
    Aresti, Unai
    Rubio, Itziar
    Arruti, Mikel
    Carrera, Sergio
    Fuente, Natalia
    Marrodan, Ines
    Lopez Escola, Cristina
    Condori, Elizabeth
    Manel Mane, Joan
    Lopez-Vivanco, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] RTOG 0625: A RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB WITH EITHER IRINOTECAN (CPT) OR DOSE-DENSE TEMOZOLOMIDE (TMZ) IN RECURRENT GLIOBLASTOMA (GBM)
    Gilbert, Mark R.
    Wang, Meihua
    Aldape, Kern
    Sorensen, A. Gregory
    Mikkelsen, Tom
    Bokstein, Felix
    Woo, Shaio Y.
    Chmura, Steven J.
    Choucair, Ali K.
    Mehta, Minesh
    NEURO-ONCOLOGY, 2010, 12 : 39 - 39
  • [43] NCCTG phase II trial of CCI-779 in recurrent glioblastoma multiforme (GBM).
    Galanis, E
    Buckner, JC
    Maurer, M
    Ballman, K
    Hidalgo, M
    Kreisberg, JI
    Boni, J
    James, CDD
    Jenkins, RB
    Walsh, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 107S - 107S
  • [44] ATEZOLIZUMAB AND BEVACIZUMAB IN RECURRENT ENDOMETRIAL CANCER: A PHASE II, MULTI INSTITUTIONAL TRIAL
    Fuh, Katherine
    Richardson, Debra
    Arend, Rebecca
    Mccourt, Carolyn
    Hagemann, Andrea
    Liang, Margaret
    Holman, Laura
    Washington, Christina
    Walker, Joan
    Mannel, Robert
    Youn, Grace
    Mutch, David
    Huh, Warner
    Cohoon, Andrew
    Leath, Charles, III
    Powell, Matthew
    Gunderson-Jackson, Camille
    Moore, Kathleen
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A8 - A8
  • [45] Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer
    Zighelboim, Israel
    Wright, Jason D.
    Gao, Feng
    Case, Ashley Stephens
    Massad, L. Stewart
    Mutch, David Gardner
    Powell, Matthew A.
    Thaker, Premal H.
    Eisenhauer, Eric Lawernce
    Cohn, David E.
    Valea, Fidel A.
    Secord, Angeles Alvarez
    Lippmann, Lynne T.
    Rader, Janet Sue
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [46] A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium.
    Jackson, Camille Catherine
    Cantrell, Leigh
    Erickson, Britt Kristina
    Moore, Kathleen N.
    Duska, Linda R.
    Richardson, Debra L.
    Landrum, Lisa Michelle
    Holman, Laura L.
    Walker, Joan L.
    Mannel, Robert S.
    Moxley, Katherine M.
    Queimado, Lurdes
    Ding, Kai
    Cohoon, Andrew
    Vesely, Sara
    Dockery, Lauren E.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial
    Peters, Katherine B.
    Vredenburgh, James J.
    Desjardins, Annick
    Friedman, Henry S.
    Herndon, James Emmett
    Coan, April D.
    McSherry, Frances
    Lipp, Eric S.
    Brickhouse, Alise
    Massey, Woody C.
    Reardon, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] Phase II trial of paclitaxel, carboplatin, and bevacizumab for advanced or recurrent cervical cancer
    Suzuki, Kazuhiro
    Nagao, Shoji
    Shibutani, Takashi
    Yamamoto, Kasumi
    Jimi, Tomoatsu
    Yano, Hiroko
    Kitai, Miho
    Shiozaki, Takaya
    Matsuoka, Kazuko
    Yamaguchi, Satoshi
    GYNECOLOGIC ONCOLOGY, 2019, 154 (03) : 554 - 557
  • [49] A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma
    Kumthekar, Priya
    Grimm, Sean Aaron
    Aleman, Roxanne T.
    Chamberlain, Marc C.
    Schiff, David
    Wen, Patrick Y.
    Iwamoto, Fabio Massaiti
    Gursel, Demirkan Besim
    Reardon, David A.
    Purow, Benjamin
    Kocherginski, Masha
    Helenowski, Irene
    Raizer, Jeffrey J.
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [50] Phase II clinical trial of bortezomib and bevacizumab combination in recurrent glioblastoma.
    Bota, D. A.
    Eroglu, Z.
    Reardon, D. A.
    Fu, B. D.
    Norfleet, J.
    Desjardins, A.
    Linskey, M. E.
    Peters, K.
    Friedman, H. S.
    Vredenburgh, J. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345